Rad51 promoter-targeted gene therapy is effective for in vivo visualization and treatment of cancer.
Hine CM, Seluanov A, Gorbunova V
Mol Ther. 2012 Feb;20(2):347-55. doi: 10.1038/mt.2011.215. Epub 2011 Oct 18.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
No plasmids are currently publicly available from Addgene for this article.